0001551306-24-000057.txt : 20240403
0001551306-24-000057.hdr.sgml : 20240403
20240403172308
ACCESSION NUMBER: 0001551306-24-000057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240304
FILED AS OF DATE: 20240403
DATE AS OF CHANGE: 20240403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sturmer Michael E
CENTRAL INDEX KEY: 0001837043
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39100
FILM NUMBER: 24820162
MAIL ADDRESS:
STREET 1: 48 LEDYARD RD
CITY: WEST HARTFORD
STATE: CT
ZIP: 06117
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Progyny, Inc.
CENTRAL INDEX KEY: 0001551306
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 272220139
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1359 BROADWAY
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: 212-888-3124
MAIL ADDRESS:
STREET 1: 1359 BROADWAY
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Auxogyn, Inc.
DATE OF NAME CHANGE: 20150318
FORMER COMPANY:
FORMER CONFORMED NAME: Auxogyn Inc
DATE OF NAME CHANGE: 20120601
4
1
wk-form4_1712179367.xml
FORM 4
X0508
4
2024-03-04
0
0001551306
Progyny, Inc.
PGNY
0001837043
Sturmer Michael E
C/O PROGYNY, INC.
1359 BROADWAY, 2ND FL
NEW YORK
NY
10018
0
1
0
0
PRESIDENT
1
Common Stock
2024-03-04
4
A
0
250000
0
A
390948
D
Common Stock
2024-04-01
4
S
0
4515
37.60
D
386433
D
Common Stock
2024-04-01
4
S
0
1880
37.60
D
384553
D
Stock Option (Right to Buy)
35.48
2024-03-04
4
A
0
600000
0
A
2034-03-03
Common Stock
600000
600000
D
Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. 25% of the RSUs will vest on March 4, 2025 with the remaining RSUs vesting in equal quarterly installments thereafter through March 4, 2028, subject to the Reporting Person's continued service through each applicable vesting date.
Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 31, 2023.
Represents an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. 25% of the shares subject to the option will vest on March 4, 2025 with the remaining shares subject to the option vesting in equal quarterly installments thereafter through March 4, 2028, subject to the Reporting Person's continued service through each applicable vesting date.
/s/ Mark Livingston, Attorney-in-Fact
2024-04-03